Olumiant

Drug Lilly USA, LLC
Total Payments
$1.9M
Transactions
1,286
Doctors
109
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2022 $1.9M 1,286 109

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1.9M 883 98.1%
Travel and Lodging $18,170 262 1.0%
Consulting Fee $13,600 2 0.7%
Food and Beverage $4,948 139 0.3%

Top Doctors Receiving Payments for Olumiant — Page 5

Doctor Specialty Location Total Records
, M D Procedural Dermatology Rome, GA $3,750 2
, PA-C Physician Assistant Rome, GA $3,473 6
, P.A Medical Oxford, AL $3,320 4
Victoria Barbosa Dermatology Chicago, IL $3,163 1
, PAC Physician Assistant Athens, TX $3,145 3
, PA Physician Assistant Pearland, TX $2,700 1
, NP Adult Health Portland, OR $2,625 2
, DNP-C Nurse Practitioner Helena, MT $2,400 2
, PHYSICIAN ASSISTANT Physician Assistant Los Angeles, CA $1,800 1

About Olumiant

Olumiant is a drug associated with $1.9M in payments to 109 healthcare providers, recorded across 1,286 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.

Payment data is available from 2022 to 2022. In 2022, $1.9M was paid across 1,286 transactions to 109 doctors.

The most common payment nature for Olumiant is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.9M, 98.1% of total).